%0 Journal Article
%T Spatial Disparity in Availability of Tuberculosis Diagnostic Services Based on Sector and Level of Care in Nigeria
%A Bethrand Odume
%A Sani Useni
%A Egwuma Efo
%A Degu Dare
%A Elias Aniwada
%A Nkiru Nwokoye
%A Ogoamaka Chukwuogo
%A Chidubem Ogbudebe
%A Michael Sheshi
%A Aminu Babayi
%A Emperor Ubochioma
%A Obioma Chijioke-Akaniro
%A Chukwumah Anyaike
%A Rupert Eneogu
%A Debby Nongo
%J Journal of Tuberculosis Research
%P 12-22
%@ 2329-8448
%D 2023
%I Scientific Research Publishing
%R 10.4236/jtr.2023.111002
%X <b><span style=\"font-family:Verdana;\">Background:</span></b><span style=\"font-family:Verdana;\"> Delay in</span><span style=\"font-family:;\" \"=\"\"> </span><span style=\"font-family:Verdana;\">Tuberculosis (TB) diagnosis can contribute to late
pres</span><span style=\"font-family:Verdana;\">entation, severe disease, and
continued transmission. KNCV TB Foundation Nigeria through the United States
Agency for International Development (USAID) </span><span style=\"font-family:Verdana;\">funded the TB Local Organization Network (LON) 1</span><span style=\"font-family:;\" \"=\"\"> </span><span style=\"font-family:Verdana;\">and 2
project</span><span style=\"font-family:Verdana;\">s</span><span style=\"font-family:Verdana;\"> that ex</span><span style=\"font-family:Verdana;\">plored
the availability of Tuberculosis services based on sector and levels of</span><span style=\"font-family:;\" \"=\"\"><span style=\"font-family:Verdana;\"> care. </span><b><span style=\"font-family:Verdana;\">Methods:</span></b><span style=\"font-family:Verdana;\"> TB Patient Pathway Analysis was carried out in 14
states comprising 92 facilities. It involved primary, secondary, and tertiary
levels of health </span><span style=\"font-family:Verdana;\">care in both the public and
private sectors. This was a cross-sectional study under program </span><span style=\"font-family:Verdana;\">implementation.
Proforma was used to collect data on the available TB diagnostic services. </span><b><span style=\"font-family:Verdana;\">Results:</span></b><span style=\"font-family:Verdana;\"> In public health facilities, GeneXpert was available at 100% in tertiary
facilities in 8 (57%) states; up to 82% in 4 (33%) states, 50% available at
secondary facilities in 2 states, and &lt; 2% in 5 states. </span><span style=\"font-family:Verdana;\">There is none at the primary facilities. Smear
microscopy was available at 100% </span><span style=\"font-family:Verdana;\">in
tertiary facilities in 9 (64%) states and 3 (25%) states have 50% to 82%;</span><span style=\"font-family:Verdana;\"> secondary -10 (71%) states have &gt; 70% at facilities; primary 1</span></span><span style=\"font-family:;\" \"=\"\"> </span><span style=\"font-family:Verdana;\">(7%) state has it in 61%
of facilities. Loop-mediated isothermal amplification (TB-LAMP) in tertiary 2</span><span style=\"font-family:;\" \"=\"\"> </span><span style=\"font-family:Verdana;\">(17%) states have 20% and
100% respectively; secondary 4</span><span style=\"font-family:;\" \"=\"\"> </span><span style=\"font-family:;\" \"=\"\"><span
%K Tuberculosis
%K Diagnostic Services
%K Disparity
%K Sector
%K Level
%K Nigeria
%U http://www.scirp.org/journal/PaperInformation.aspx?PaperID=123532